Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03910660
Title A Trial of BXCL701 and Pembrolizumab in Patients With Small Cell Neuroendocrine Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors BioXcel Therapeutics Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR

Facility Status City State Zip Country Details
University of California San Francisco (UCSF) San Francisco California 94158 United States Details
BioXcel Clinical Research Site Denver Colorado 80211 United States Details
Yale University New Haven Connecticut 06510 United States Details
Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
BioXcel Clinical Research Site Detroit Michigan 48201 United States Details
Center for Advanced Medicine / R.J. Zuckerberg Cancer Center (Northwell Health Cancer Institute) Lake Success New York 11042 United States Details
Weill Cornell Medicine New York New York New York 10021 United States Details
White Plains Hospital Center for Cancer Care White Plains New York 10601 United States Details
The Ohio State University Columbus Ohio 43210 United States Details
BioXcel Clinical Research Site Glasgow England G12 0YN United Kingdom Details
BioXcel Clinical Research Site London Great Britain W1T 7HA United Kingdom Details
BioXcel Clinical Research Site Sutton Surrey SM2 5NG United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field